1 Session 14. Getting Started Drug and Therapeutics Committee.

Slides:



Advertisements
Similar presentations
Common/shared responsibilities between jobs.
Advertisements

Post Research Benefits Mandika Wijeyaratne MS, MD, FRCS Dept. of Surgery, Colombo.
5th Annual PBM Pharmacy Informatics Conference
The Aged Care Standards and Accreditation Agency Ltd Continuous Improvement in Residential Aged Care.
Bryan Roach Chairman Crime Stoppers Australia. Strategic Planning The process for defining strategy (direction) and decision making For Crime Stoppers,
Department of Medicine Three Year Review Workshop Job Descriptions November 21, 2012 Joan Wither Co-Chair, Three Year Review Joan Wither Co-Chair, Three.
MEDICINES SELECTION & FORMULARY MANAGEMENT
SESSION 2 Key points Module 4 covers consultation requirements under the WHS Act and relies on participants having completed Modules 1 – 3 of this course.
Continuous Quality Improvement – Knowledge Management by Any Other Name Peter Hobby Director of Communications and KM Center for Pharmaceutical Management.
Drug Utilization Review (DUR)
Bree Collaborative Cardiology Report: Appropriateness of Percutaneous Cardiac Interventions (PCI) Bree Collaborative Meeting November 30, 2012.
The situation The requirements The benefits What’s needed to make it work How to move forward.
The ICH E5 Question and Answer Document Status and Content Robert T. O’Neill, Ph.D. Director, Office of Biostatistics, CDER, FDA Presented at the 4th Kitasato-Harvard.
IS Audit Function Knowledge
By Saurabh Sardesai October 2014.
Evaluation. Practical Evaluation Michael Quinn Patton.
a judgment of what constitutes good or bad Audit a systematic and critical examination to examine or verify.
Hospital Patient Safety Initiatives: Discharge Planning
Promoting Excellence in Family Medicine Enabling Patients to Access Electronic Health Records Guidance for Health Professionals.
Drug and Therapeutics Committee Session 7A. Identifying Problems with Medicine Use: Indicator Studies.
Community Planning Training 1-1. Community Plan Implementation Training 1- Community Planning Training 1-3.
1 Drug and Therapeutics Committee. Objectives  Discuss the use of aggregate data including defined daily dose in analyzing the consumption of medicines.
Quality Improvement Prepeared By Dr: Manal Moussa.
Introduction to Standard 2: Partnering with consumers Advice Centre Network Meeting Nicola Dunbar October 2012.
1 CHCOHS312A Follow safety procedures for direct care work.
Health promotion and health education programs. Assumptions of Health Promotion Relationship between Health education& Promotion Definition of Program.
Performance Measurement and Analysis for Health Organizations
W231 Applied Research Project Solving a Problem for a Local Business or Organization.
The Audit Process Tahera Chaudry March Clinical audit A quality improvement process that seeks to improve patient care and outcomes through systematic.
Summary from the Economics Track With thanks to all track participants, presenters, rapporteurs, moderators and organizers.
IAOD Evaluation Section, the Development Agenda (DA) and Development Oriented Activities Julia Flores Marfetan, Senior Evaluator.
MOD 6050 PROJECT MANAGEMENT AND FUND RAISING TOPIC – PROPOSAL WRITING AND FUNDRAISING (WK 6 &8) LECTURER: DR. G. O. K’AOL.
Project Charters Module 3
Promoting Drug and Therapeutics Committees in the Developing World
ASPECTS AFFECTING THE HOSPITAL OPERATION Financial Financial Operational Operational Administrative Administrative Clinical Clinical Safety Safety.
CHAPTER 28 Translation of Evidence into Nursing Practice: Evidence, Clinical practice guidelines and Automated Implementation Tools.
CHAPTER V Health Information. Updates on new legislation (1)  Decision No.1605/2010/QĐ-TTg approving the National Program for Application of information.
Using drug use evaluation (DUE) to optimise analgesic prescribing in emergency departments (EDs) Karen Kaye, Susie Welch. NSW Therapeutic Advisory Group*
{ NOPH Unit Council Program Partnering for Excellence.
Making Tough Choices: A journey to improve Engagement and Transparency National Health Leaders Conference June 16, 2015.
CAMBODIA EXPERIENCE ON MTP (MONITORING, TRAINING, PLANNING) TO REDUCE INAPPROPRIATE MEDICINE USE IN HOSPITALS.
Performance Improvement Project Validation Process Outcome Focused Scoring Methodology and Critical Analysis Presenter: Christi Melendez, RN, CPHQ Associate.
TCRF Strategic Planning Process A Stakeholders’ Consultative Retreat- Morogoro 26 th -27 April 2013.
Pethidine prescribing in the ED… Let’s be rational! Kaye KI, Maxwell DJ, Graudins L, on behalf of the the NSW Therapeutic Assessment Group (NSW TAG) Drug.
Session 6: Data Flow, Data Management, and Data Quality.
Session 2: Developing a Comprehensive M&E Work Plan.
Department of Health The Australian Charter of Healthcare Rights in Victoria Your role in realising the Australian Charter of Healthcare Rights in Victoria.
Verification, Validation and Internal Audits - Jose Jimenez Federal Facilities Program Manager – EPA Region III.
Kerstin Ödman Chair of the Strategy Working Group Ad hoc NDPHS Strategy Working Group Report for the NDPHS committee of Senior Representatives Riga,
Development of Gender Sensitive M&E: Tools and Strategies.
Establishment of QIT and WIT 5S Training of Trainers for Training Institutions Training material No. 24.
What is a Service Level Agreement? Service level agreements are part of a quality approach to help teams identify and agree what ‘good quality’ looks like.
Given the progress that continues to be made in society’s battle against disease, patients are seeking more information about medical problems and potential.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 6 CH 5 ISO MANAGEMENT RESPONSIBILITY Philippe Bauwin Medical.
Cindy Tumbarello, RN, MSN, DHA September 22, 2011.
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
ABSTRACT THE IMPACT OF CONTINUOUS MEDICAL EDUCATION ON PRESCRIBING HABITS IN MISSION HOSPITALS IN KENYA By John Kiambuthi Mission for essential drugs and.
Evaluation What is evaluation?
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Outline of Quality assurance and accreditation
HOSPITAL ACCREDITATION & RETAINING QUALITY
Performance Improvement Project Validation Process Outcome Focused Scoring Methodology and Critical Analysis Presenter: Christi Melendez, RN, CPHQ Associate.
Promoting Drug and Therapeutics Committees in the Developing World
ABSTRACT THE IMPACT OF CONTINUOUS MEDICAL EDUCATION ON PRESCRIBING
Monitoring and Evaluation Systems for NARS Organisations in Papua New Guinea Day 3. Session 8. Routine monitoring.
ABSTRACT Problem statement: The Lao PDR National Drug Policy (NDP) Program, implemented by the Ministry of Health supported by the Swedish International.
Performance Improvement Project Validation Process Outcome Focused Scoring Methodology and Critical Analysis Presenter: Christi Melendez, RN, CPHQ Associate.
Results of the Organizational Performance
Performance and Quality Improvement
Presentation transcript:

1 Session 14. Getting Started Drug and Therapeutics Committee

Objectives  Understand the basics of starting a DTC where none exists  Understand how to improve the functioning of an existing DTC  Identify and solve management and medicine use problems in establishing and maintaining a DTC

Addressing the Problem  The way to get started will depend on local circumstances, including the health care system and hospital  DTCs have to deal with many issues but cannot do everything all at once – so concentrate on only 1-2 issues at a time especially in the beginning  The first step is for YOU to realize there is a problem and that the DTC can provide a framework for solutions  Thereafter, you must convince others of the need to address the problem and work with them on solutions

Step 1. Do the Groundwork Build evidence for advocacy by determining —  Whether data on medicine use problems is available. If so, collect it.  Whether senior health staff think medicine use problems exist. If so—  What kind of problems?  How serious are they?  How can the most serious problems be addressed?  Document what they say.

Step 2. Gain a Friend in Authority  Share the findings of your initial groundwork with the most senior medical authority  Present any useful data and discuss how it might negatively affect patient outcome or increase hospital budget  Plan a course of action with the senior medical authority

Step 3. Meet Relevant Stakeholders  With the approval of senior management, meet all senior health staff to discuss medicine use problems  Present your groundwork findings  Present medicine use data (e.g., ABC analysis, indicators)  If all agree that medicine use problems are a serious issue, take the opportunity to discuss establishing a DTC

Step 4. Measure Your Medicine Use Problem  Involve senior staff in these important activities—  VEN analysis  ABC analysis  Compare VEN and ABC  Medicine use indicator studies (health facility and hospital indicators)

Step 5. Present Findings, and Plan the Next Steps with your Stakeholders  Analyze potential medicines use problems and obtain consensus on how to solve them  Use this opportunity to discuss establishing a DTC  If causes are well understood, then solutions can be found by stakeholders  Stakeholders’ meeting is an opportunity to demonstrate how a DTC can function

Step 6. Undertake a Detailed Medicine Use Investigation A DUE of one or two medicines may be done according to whether the medicine—  Has the highest value  Has serious side-effects  Is nonessential  Has more consumption than expected from morbidity patterns

Step 7. Present Your Detailed Findings to Stakeholders, and Plan an Intervention  Present your results and analysis  Mention how much time it took, and thank all those who participated  Discuss and agree with stakeholders and senior prescribers a plan of action which may include—  Targeted intervention based on the detailed findings and involving the senior prescribers  Initiating a formulary process or other general means to improve medicine use  Use the opportunity to discuss having a DTC  Record minutes of the meeting

Step 8. Implement and Evaluate the Agreed-upon Intervention  Type of intervention(s) will depend on the type of medicine use problem and the underlying reasons for it that have been identified  Educational, managerial, or regulatory  Implement and evaluate interventions with the full cooperation and involvement of stakeholders and senior prescribers.  Measure the cost of the intervention and any savings in terms of less drug used or different medicines used

Step 9. Present the Results of Your Interventions to Senior Prescribers  Present the results of your findings to senior management and prescribers  If they have been properly involved they will already know some of the results  Emphasize during the presentation  Benefits in terms of better health care and reduced costs  Need for time and resources to achieve an improved result  Need for a sustainable mechanism to conduct such work and how a DTC could provide this

Step 10. Plan the Start of a DTC  Plan the start of a DTC  If you have followed the previous steps administration and senior staff, whom you have kept fully informed, should support you  Develop terms of reference (TOR)  Select members  Representing key stakeholders  Get approval and buy-in from hospital administration and senior physicians

Revitalizing Nonfunctioning DTCs  Probe for reasons why the DTC is nonfunctional  If staff are unaware of medicine use problems, demonstrate the problems and their underlying causes  Examine why DTC members are not active and determine what can be done to improve participation  If the DTC has ceased to function because a specific issue cannot be resolved, seek senior medical authority involvement

Activity Each group should work on an assigned DTC- related problem and develop solutions Develop a presentation to include—  A succinct description of the problem and the reasons underlying the problem  A practical plan of action to solve the problem

Summary In conclusion, getting a DTC started or making it more functional will require a strategy based on—  Local conditions  Local data  Starting small and then scaling up  Choosing a problem that can easily be addressed  Transparent decision making  Political and administrative support